Thymosin Alpha-1

Thymosin Alpha-1 (Tα1) is a 28-amino acid peptide naturally produced by the thymus gland, where it plays a critical role in T-cell maturation, immune surveillance, and immune system homeostasis. Originally isolated from thymosin fraction 5 by Dr. Allan Goldstein, Tα1 is one of the most clinically validated immunomodulatory peptides, approved in over 35 countries for various indications. Its mechanism of action involves activation of Toll-like receptors (TLR2, TLR9) on dendritic cells, promotion of T-cell maturation and differentiation (particularly CD4+ and CD8+ subsets), enhancement of natural killer (NK) cell cytotoxicity, increased production of IFN-α and IFN-γ, and modulation of the Th1/Th2 cytokine balance toward a Th1 response. Research applications span immune deficiency restoration, chronic hepatitis B and C adjunct therapy studies, vaccine adjuvant development, tumor immunology (through enhancement of tumor antigen presentation), sepsis and critical illness immune restoration, and aging-related immunosenescence research. Tα1 has also been studied for its potential to restore immune function following chemotherapy or radiation-induced immunosuppression.